Literature DB >> 25864641

Evaluation of anhedonia with the Snaith-Hamilton Pleasure Scale (SHAPS) in adult outpatients with major depressive disorder.

Paul A Nakonezny1, David W Morris2, Tracy L Greer2, Matthew J Byerly2, Thomas J Carmody1, Bruce D Grannemann2, Ira H Bernstein1, Madhukar H Trivedi3.   

Abstract

Anhedonia or inability to experience pleasure not only is a core symptom of major depressive disorder (MDD), but also is identified as an important component of the positive valence system in the NIMH Research Domain Criteria. The Snaith-Hamilton Pleasure Scale (SHAPS) has been developed for the assessment of hedonic experience or positive valence, but has not been well-studied in depressed outpatient populations. The current study examined the reliability and validity of the SHAPS using a sample of adult outpatients with treatment resistant MDD. Data for the current study were obtained from 122 adult outpatients with a diagnosis of MDD and non-response to adequate treatment with an SSRI and who participated in Project TReatment with Exercise Augmentation for Depression (TREAD). A Principal Components Analysis was used to define the dimensionality of the SHAPS. Convergent and discriminant validity were evaluated via correlations of the SHAPS total score with "gold standard" measures of depression severity and quality of life. The SHAPS was found to have high internal consistency (Cronbach's coefficient α = .82). A Principal Components Analysis suggests that the SHAPS is mainly "unidimensional" and limited to hedonic experience among adult outpatients with MDD. Convergent and discriminant validity were assessed by examining the Spearman rank-order correlation coefficient between the SHAPS total score and the HRSD17 (rs = 0.22, p < .03), IDS-C30 (rs = 0.26, p < .01), IDS-SR30 (rs = 0.23, p < .02), QIDS-C16 (rs = 0.22, p < .03), QIDS-SR16 (rs = 0.17, p < .10), QLES-Q (rs = -0.32, p < .002), and the pleasure/enjoyment item (sub-item 21) of the IDS-C (rs = 0.44, p < .0001) and IDS-SR (rs = 0.38, p < .0002). The self-administered SHAPS showed modest sensitivity (76%) and specificity (54%) with the self-administered pleasure/enjoyment single item (sub-item 21) of IDS-SR30. The current study shows that the SHAPS is a reliable and valid instrument to assess hedonic experience or positive valence in adult outpatients with MDD and provides a broader assessment of this important domain.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anhedonia; Hedonic experience; Major depressive disorder; Snaith–Hamilton

Mesh:

Year:  2015        PMID: 25864641      PMCID: PMC7505238          DOI: 10.1016/j.jpsychires.2015.03.010

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  27 in total

Review 1.  The state-trait disjunction of anhedonia in schizophrenia: potential affective, cognitive and social-based mechanisms.

Authors:  Alex S Cohen; Gina M Najolia; Laura A Brown; Kyle S Minor
Journal:  Clin Psychol Rev       Date:  2010-11-12

2.  Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's disease.

Authors:  Matthias R Lemke; H Michael Brecht; Juergen Koester; Heinz Reichmann
Journal:  J Neurol Sci       Date:  2006-06-30       Impact factor: 3.181

3.  A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale.

Authors:  R P Snaith; M Hamilton; S Morley; A Humayan; D Hargreaves; P Trigwell
Journal:  Br J Psychiatry       Date:  1995-07       Impact factor: 9.319

4.  Hamilton rating scale for depression with medical in-patients.

Authors:  J J Schwab; M R Bialow; R S Clemmons; C E Holzer
Journal:  Br J Psychiatry       Date:  1967-01       Impact factor: 9.319

5.  Exercise as an augmentation treatment for nonremitted major depressive disorder: a randomized, parallel dose comparison.

Authors:  Madhukar H Trivedi; Tracy L Greer; Timothy S Church; Thomas J Carmody; Bruce D Grannemann; Daniel I Galper; Andrea L Dunn; Conrad P Earnest; Prabha Sunderajan; Steven S Henley; Steven N Blair
Journal:  J Clin Psychiatry       Date:  2011-05       Impact factor: 4.384

6.  Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure.

Authors:  J Endicott; J Nee; W Harrison; R Blumenthal
Journal:  Psychopharmacol Bull       Date:  1993

7.  The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation.

Authors:  M H Trivedi; A J Rush; H M Ibrahim; T J Carmody; M M Biggs; T Suppes; M L Crismon; K Shores-Wilson; M G Toprac; E B Dennehy; B Witte; T M Kashner
Journal:  Psychol Med       Date:  2004-01       Impact factor: 7.723

8.  A new depression scale designed to be sensitive to change.

Authors:  S A Montgomery; M Asberg
Journal:  Br J Psychiatry       Date:  1979-04       Impact factor: 9.319

9.  The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.

Authors:  A John Rush; Madhukar H Trivedi; Hicham M Ibrahim; Thomas J Carmody; Bruce Arnow; Daniel N Klein; John C Markowitz; Philip T Ninan; Susan Kornstein; Rachel Manber; Michael E Thase; James H Kocsis; Martin B Keller
Journal:  Biol Psychiatry       Date:  2003-09-01       Impact factor: 13.382

Review 10.  Anhedonia: a neglected symptom of psychopathology.

Authors:  P Snaith
Journal:  Psychol Med       Date:  1993-11       Impact factor: 7.723

View more
  11 in total

1.  Psychometric properties the of Brazilian Portuguese version of Snaith-Hamilton Pleasure Scale (SHAPS).

Authors:  Ana Paula Jesus-Nunes; João Paulo Barreto Borges Coroa; Felipe Coelho Argolo; Tayne de Miranda Moreira; Mychelle Morais-de-Jesus; Roberta Ferrari Marback; Fernanda S Correia-Melo; Acioly L T Lacerda; Lucas C Quarantini
Journal:  Trends Psychiatry Psychother       Date:  2021-01-22

2.  Psychometrics of the Self-Report Concise Associated Symptoms Tracking Scale (CAST-SR): Results From the STRIDE (CTN-0037) Study.

Authors:  Joseph M Trombello; Michael O Killian; Allen Liao; Katherine Sanchez; Tracy L Greer; Robrina Walker; Bruce Grannemann; Chad D Rethorst; Thomas Carmody; Madhukar H Trivedi
Journal:  J Clin Psychiatry       Date:  2018 Mar/Apr       Impact factor: 4.384

3.  Parsing the heterogeneity of depression: An exploratory factor analysis across commonly used depression rating scales.

Authors:  Elizabeth D Ballard; Julia S Yarrington; Cristan A Farmer; Marc S Lener; Bashkim Kadriu; Níall Lally; Deonte Williams; Rodrigo Machado-Vieira; Mark J Niciu; Lawrence Park; Carlos A Zarate
Journal:  J Affect Disord       Date:  2018-02-05       Impact factor: 4.839

4.  Exercise is an effective treatment for positive valence symptoms in major depression.

Authors:  Marisa Toups; Thomas Carmody; Tracy Greer; Chad Rethorst; Bruce Grannemann; Madhukar H Trivedi
Journal:  J Affect Disord       Date:  2016-10-15       Impact factor: 4.839

5.  Unique and Transdiagnostic Dimensions of Reward Functioning in Attention-Deficit/Hyperactivity Disorder and Alcohol Use Disorder Symptoms.

Authors:  Lauren E Oddo; Samuel F Acuff; Melanie B Arenson; Assaf Oshri; Andrea Chronis-Tuscano; James MacKillop; James G Murphy
Journal:  Alcohol Alcohol       Date:  2022-07-09       Impact factor: 3.913

6.  Anhedonia is associated with blunted reward sensitivity in first-degree relatives of patients with major depression.

Authors:  Wen-Hua Liu; Jonathan P Roiser; Ling-Zhi Wang; Yu-Hua Zhu; Jia Huang; David L Neumann; David H K Shum; Eric F C Cheung; Raymond C K Chan
Journal:  J Affect Disord       Date:  2015-11-10       Impact factor: 4.839

7.  A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedonia.

Authors:  Andrew D Krystal; Diego A Pizzagalli; Moria Smoski; Sanjay J Mathew; John Nurnberger; Sarah H Lisanby; Dan Iosifescu; James W Murrough; Hongqiu Yang; Richard D Weiner; Joseph R Calabrese; Gerard Sanacora; Gretchen Hermes; Richard S E Keefe; Allen Song; Wayne Goodman; Steven T Szabo; Alexis E Whitton; Keming Gao; William Z Potter
Journal:  Nat Med       Date:  2020-03-30       Impact factor: 53.440

8.  Differentiating Melancholic and Non-melancholic Major Depressive Disorder Using Fractional Amplitude of Low-Frequency Fluctuations.

Authors:  Yingying Zhang; Xilong Cui; Yangpan Ou; Feng Liu; Huabing Li; Jindong Chen; Jingping Zhao; Guangrong Xie; Wenbin Guo
Journal:  Front Psychiatry       Date:  2022-02-02       Impact factor: 4.157

9.  Effects of transcranial magnetic stimulation on anhedonia in treatment resistant major depressive disorder.

Authors:  Andrew M Fukuda; Jee Won Diane Kang; Asi Polly Gobin; Eric Tirrell; Fatih Kokdere; Linda L Carpenter
Journal:  Brain Behav       Date:  2021-08-28       Impact factor: 2.708

10.  Physical and social anhedonia in female adolescents: A factor analysis of self-report measures.

Authors:  Xi Yang; Melynda D Casement; Kate E Keenan; Alison E Hipwell; Amanda E Guyer; Erika E Forbes
Journal:  Emotion       Date:  2021-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.